MS Patients Suffer Side-effects

This is a London news story, published by Guardian, that relates primarily to Laura Thomas news.

London news

For more London news, you can click here:

more London news

Laura Thomas news

For more Laura Thomas news, you can click here:

more Laura Thomas news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Guardian news

For more news from Guardian, you can click here:

more news from Guardian

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

MS patients

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Multiple Sclerosis Trust news, MS symptoms news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

multiple sclerosis

Guardian

•

Health

MS patients suffer side-effects after NHS England switches to cheaper drug

Summary

Nutrition label

71% Informative

About 170 MS patients at Charing Cross hospital in London have had complications, including a relapse of their illness, after being switched from Tysabri to a different drug called Tyruko .

In a handful of cases, the people affected developed such serious symptoms that they had to be taken to hospital for treatment.

Patients have told doctors about an inability to use their legs, other mobility problems, fatigue, pain and sudden weight gain.

Laura Thomas , head of policy at the MS Society , said: “Some people have told our MS helpline they’ve started experiencing side-effects since switching from Tysabri to Tyruko, and some have told us they’re unsure if Tyruko is as effective. However, there are many others who haven’t reported any issues at all.”.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful